Pink, Painful Nodules: A Case of Cutaneous Metastatic Breast Adenocarcinoma

Main Article Content

Rachel Elsanadi
University of California, Irvine, Department of Dermatology

Anna-Marie Hosking
University of California, Irvine, Department of Dermatology

Patrick Lee
University of California, Irvine, Department of Dermatology

Keywords

cancer, metastatic, breast cancer, women's health, USPSTF, histology, dermatopathology, cutaneous metastasis

References

1. Araújo E, Barbosa M, Costa R, Sousa B, Costa V. A First Sign Not to be Missed: Cutaneous Metastasis from Breast Cancer. Eur J Case Rep Intern Med. 2020;7(1):001356. Published 2020 Jan 8. doi:10.12890/2020_001356

2. Johnson C, Friedmann DP, Gade A, Dhawan N, Hinchee-Rodriguez K, Mishra V et al. Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systematic Review. Cutis. 2021 Mar;107(3):E29-E36. doi: 10.12788/cutis.0223. PMID: 33956620.

3. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004 Jul;31(6):419-30. doi: 10.1111/j.0303-6987.2004.00207.x. PMID: 15186430.

4. Sanae A, Kaoutar I, Jamal EF, Meryem E. Cutaneous metastasis as a first sign of breast carcinoma. Radiol Case Rep. 2021 May 26;16(7):1899-1901. doi: 10.1016/j.radcr.2021.04.064. PMID: 34113415; PMCID: PMC8170009.

5. Ferreira VA, Spelta K, Diniz LM, Lucas EA. Exuberant case of cutaneous metastasis of breast cancer. An Bras Dermatol. 2018 Jun;93(3):429-431. doi: 10.1590/abd1806-4841.20187157. PMID: 29924228; PMCID: PMC6001113.

6. Teyateeti P, Ungtrakul T. Retrospective review of cutaneous metastasis among 11,418 patients with solid malignancy: A tertiary cancer center experience. Medicine (Baltimore). 2021 Jul 23;100(29):e26737. doi: 10.1097/MD.0000000000026737. PMID: 34398051; PMCID: PMC8294925.

Article Sidebar

PDF
Published
Sep 15, 2023
DOI https://doi.org/10.25251/skin.7.5.18

Article Details

How to Cite
[1]
Elsanadi, R., Hosking, A.-M. and Lee, P. 2023. Pink, Painful Nodules: A Case of Cutaneous Metastatic Breast Adenocarcinoma. SKIN The Journal of Cutaneous Medicine. 7, 5 (Sep. 2023), 1056–1058. DOI:https://doi.org/10.25251/skin.7.5.18.
Issue
Vol. 7 No. 5 (2023): September 2023 Issue
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)